These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28069485)

  • 41. One science-driven approach for the regulatory implementation of alternative methods: A multi-sector perspective.
    Dal Negro G; Eskes C; Belz S; Bertein C; Chlebus M; Corvaro M; Corvi R; Dhalluin S; Halder M; Harvey J; Hermann M; Hoffmann-Dörr S; Kilian K; Lambrigts D; Laroche C; Louhimies S; Mahony C; Manou I; McNamee P; Prieto P; Reid K; Roggen E; Schutte K; Stirling C; Uhlrich S; Weissenhorn R; Whelan M
    Regul Toxicol Pharmacol; 2018 Nov; 99():33-49. PubMed ID: 30098372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. State of the science on alternatives to animal testing and integration of testing strategies for food safety assessments: Workshop proceedings.
    Karmaus AL; Bialk H; Fitzpatrick S; Krishan M
    Regul Toxicol Pharmacol; 2020 Feb; 110():104515. PubMed ID: 31705943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SEURAT: Safety Evaluation Ultimately Replacing Animal Testing--recommendations for future research in the field of predictive toxicology.
    Daston G; Knight DJ; Schwarz M; Gocht T; Thomas RS; Mahony C; Whelan M
    Arch Toxicol; 2015 Jan; 89(1):15-23. PubMed ID: 25433540
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Replacement of in vivo acute oral toxicity studies by in vitro cytotoxicity methods: opportunities, limits and regulatory status.
    Ukelis U; Kramer PJ; Olejniczak K; Mueller SO
    Regul Toxicol Pharmacol; 2008 Jun; 51(1):108-18. PubMed ID: 18362045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acute Toxicity Prediction in Multiple Species by Leveraging Mechanistic ToxCast Mitochondrial Inhibition Data and Simulation of Oral Bioavailability.
    Bhhatarai B; Wilson DM; Bartels MJ; Chaudhuri S; Price PS; Carney EW
    Toxicol Sci; 2015 Oct; 147(2):386-96. PubMed ID: 26139166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Advancing the 3Rs in regulatory ecotoxicology: A pragmatic cross-sector approach.
    Burden N; Benstead R; Clook M; Doyle I; Edwards P; Maynard SK; Ryder K; Sheahan D; Whale G; van Egmond R; Wheeler JR; Hutchinson TH
    Integr Environ Assess Manag; 2016 Jul; 12(3):417-21. PubMed ID: 26440537
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CATMoS: Collaborative Acute Toxicity Modeling Suite.
    Mansouri K; Karmaus AL; Fitzpatrick J; Patlewicz G; Pradeep P; Alberga D; Alepee N; Allen TEH; Allen D; Alves VM; Andrade CH; Auernhammer TR; Ballabio D; Bell S; Benfenati E; Bhattacharya S; Bastos JV; Boyd S; Brown JB; Capuzzi SJ; Chushak Y; Ciallella H; Clark AM; Consonni V; Daga PR; Ekins S; Farag S; Fedorov M; Fourches D; Gadaleta D; Gao F; Gearhart JM; Goh G; Goodman JM; Grisoni F; Grulke CM; Hartung T; Hirn M; Karpov P; Korotcov A; Lavado GJ; Lawless M; Li X; Luechtefeld T; Lunghini F; Mangiatordi GF; Marcou G; Marsh D; Martin T; Mauri A; Muratov EN; Myatt GJ; Nguyen DT; Nicolotti O; Note R; Pande P; Parks AK; Peryea T; Polash AH; Rallo R; Roncaglioni A; Rowlands C; Ruiz P; Russo DP; Sayed A; Sayre R; Sheils T; Siegel C; Silva AC; Simeonov A; Sosnin S; Southall N; Strickland J; Tang Y; Teppen B; Tetko IV; Thomas D; Tkachenko V; Todeschini R; Toma C; Tripodi I; Trisciuzzi D; Tropsha A; Varnek A; Vukovic K; Wang Z; Wang L; Waters KM; Wedlake AJ; Wijeyesakere SJ; Wilson D; Xiao Z; Yang H; Zahoranszky-Kohalmi G; Zakharov AV; Zhang FF; Zhang Z; Zhao T; Zhu H; Zorn KM; Casey W; Kleinstreuer NC
    Environ Health Perspect; 2021 Apr; 129(4):47013. PubMed ID: 33929906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Implementation challenges for designing integrated in vitro testing strategies (ITS) aiming at reducing and replacing animal experimentation.
    De Wever B; Fuchs HW; Gaca M; Krul C; Mikulowski S; Poth A; Roggen EL; Vilà MR
    Toxicol In Vitro; 2012 Apr; 26(3):526-34. PubMed ID: 22269383
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Testing strategies for embryo-fetal toxicity of human pharmaceuticals. Animal models vs. in vitro approaches: a workshop report.
    van der Laan JW; Chapin RE; Haenen B; Jacobs AC; Piersma A
    Regul Toxicol Pharmacol; 2012 Jun; 63(1):115-23. PubMed ID: 22449444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluating opportunities for advancing the use of alternative methods in risk assessment through the development of fit-for-purpose in vitro assays.
    McMullen PD; Andersen ME; Cholewa B; Clewell HJ; Dunnick KM; Hartman JK; Mansouri K; Minto MS; Nicolas CI; Phillips MB; Slattery S; Yoon M; Clewell RA
    Toxicol In Vitro; 2018 Apr; 48():310-317. PubMed ID: 29391263
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Toxicology in the 21st century--working our way towards a visionary reality.
    Berg N; De Wever B; Fuchs HW; Gaca M; Krul C; Roggen EL
    Toxicol In Vitro; 2011 Jun; 25(4):874-81. PubMed ID: 21338664
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computational chemistry, systems biology and toxicology. Harnessing the chemistry of life: revolutionizing toxicology. a commentary.
    Kimber I; Humphris C; Westmoreland C; Alepee N; Negro GD; Manou I
    J Appl Toxicol; 2011 Apr; 31(3):206-9. PubMed ID: 21404310
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 3Rs implementation in veterinary vaccine batch-release testing: Current state-of-the-art and future opportunities. A webinar and workshop report.
    Viviani L; Balks E; Beken S; Brady AM; Clayton R; Cliquet F; Desmayanti L; Fragoeiro S; Hamtak TJ; John D; Jungbaëck C; Kalaivani M; Kross I; Lang C; Ria Isriyanthi NM; Mallet L; Milne C; Rubbrecht M; Siklódi B; Singh B; Srinivas GB; Stickings P; Stirling C; Sundram P; Szabó M; Thomas A; van den Berg M; Walker A; Philippe C; Vandeputte J
    Biologicals; 2023 Aug; 83():101695. PubMed ID: 37516084
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acute oral toxicity testing: Scientific evidence and practicability should govern Three Rs activities.
    Buesen R; Oberholz U; Sauer UG; Landsiedel R
    Altern Lab Anim; 2016 Sep; 44(4):391-398. PubMed ID: 27685189
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dermal and inhalation acute toxic class methods: test procedures and biometric evaluations for the Globally Harmonized Classification System.
    Holzhütter HG; Genschow E; Diener W; Schlede E
    Arch Toxicol; 2003 May; 77(5):243-54. PubMed ID: 12734637
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A new path forward: the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) and National Toxicology Program's Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM).
    Casey W; Jacobs A; Maull E; Matheson J; Clarke C; Lowit A
    J Am Assoc Lab Anim Sci; 2015 Mar; 54(2):170-3. PubMed ID: 25836963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploring waiving opportunities for mammalian acute systemic toxicity tests.
    Graepel R; Asturiol D; Prieto P; Worth AP
    Altern Lab Anim; 2016 Jul; 44(3):271-9. PubMed ID: 27494626
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Principles and guidelines for the development of a science-based decision making process facilitating the implementation of the 3Rs by governmental regulators.
    Gauthier C
    ILAR J; 2002; 43 Suppl():S99-S104. PubMed ID: 12388860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.